DOCSLIB.ORG

1 True/False (1 Point Each) __F__ 1. Mature B Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
1 True/False (1 Point Each) __F__ 1. Mature B Cells MICROBIO320 EXAM 1-Fall 2009 Name _____________________________ True/False (1 point each) __F__ 1. Mature B cells (lymphocytes) bind only to processed antigen. __F__ 2. The intrinsic pathway of programmed cell death relies on the death receptor called FAS. __F__ 3. Natural Killer cells proliferate in response to antigen. __F__ 4. In the 21st century, the leading cause of death in the United States is infectious disease. __T__ 5. MHC Class I molecules are found on all nucleated cell types. __F__ 6. Mature, fully differentiated T cells are found in the cortex of the thymus. __F__ 7. B Cells are not subjected to central tolerance. __F__ 8. Relatively speaking, the innate immune system is a slow response while the adaptive immune system is a very fast response. __F__ 9. Only immature T lymphocytes are subjected to peripheral tolerance. __T__10. Antigen is presented to T cell mainly in secondary lymphoid organs. __T__11. C3 is the most abundant complement component in the body. __T__12. T cell receptors are composed of constant and variable regions. __T__13. Mucosal membrane are collectively considered the largest anatomical barrier for the innate immune system. __F__14. The innate immune system is not capable of recognizing carbohydrate and lipids on the surface of common pathogens. __T__15. Peripheral tolerance is an important mechanism to prevent autoimmune disease. __T__16. Macrophage cells are considered "professional phagocytes." /16 1 MICROBIO320 EXAM 1-Fall 2009 Name _____________________________ Fill-in List the three (3) different complement pathways. For each, fill in what the complement components are recognizing. For example: general pathogen surface. (6 pts) Complement Pathway Complement Components Recognize: 17. CLASSICAL PATHWAY 18. ANTIGEN/ ANTIBODY COMPLEXES 19. MANNOSE-BINDING LECTIN PATWAY 20. MANNOSE ON PATHOGEN SURFACE 21. ALTERNATIVE PATHWAY 22. GENERAL PATHOGEN SURFACES For each column, simply answer yes or no for each of the properties listed. (8 pts) Properties Immunoglobulin T Cell Receptor Secreted forms 23. YES 24. NO VDJ recombination 25. YES 26. YES Transmembrane forms 27. YES 28. YES For the following table, please fill in either TH1 or TH2. The functions below are related to when the T Cell subtype is activated. Properties Helper T cell subtype Releases the cytokine IFNγ 31. TH1 Coordinates responses to extracellular pathogens 32. TH2 Releases the cytokine IL4 33. TH2 Macrophage activation 34. TH1 Please list four (4) of the major events of phagocytosis. Phagocytic Events (I excepted any of the 5 following or something close) 35. CHEMOTAXIS 36. ADHERENCE 37. INGESTION 38. KILLING LASTLY, ELIMINATION /20 2 MICROBIO320 EXAM 1-Fall 2009 Name _____________________________ Define the following terms: Please keep to a single sentence (each 1 pt) 39. Surfactant - A wetting agent that lowers the surface tension. A surface-active lipoprotein complex formed by type II alveolar cells. 40. Apoptosis - Programmed cell death, death by suicide that is INDUCED. This process involves a series of biochemical reaction involving caspases. 41. Anergy - Describes the lack of reaction by the body's defense mechanisms to foreign substances, and is a direct induction of peripheral lymphocyte tolerance. 42. Epitope - Portion of a marcomolecule to which an antibody binds; the antigenic determinant. Indicate two reasons why life expectancy has increased since the 1900's. (There were at least 8 possible reasons listed in Lecture 1) 43. 44. 45-46. How does normal flora act as part of the innate immune system? (2pts) Approximately 100 trillion bacteria and other microorganisms reside in or on the human body. These normal body flora keep potentially harmful opportunistic pathogens in check and also inhibit the colonization of pathogens by: a. producing metabolic products (fatty acids, bacteriocins, etc.) that inhibit the growth of many pathogens; b. b. adhering to target host cells thus covering them and preventing pathogens from colonizing; c. c. depleting nutrients essential for the growth of pathogens; and d. d. nonspecifically stimulating the immune system. 47-50. Briefly describe the concept behind central tolerance of T lymphocytes. (4 pts) Include in your answer positive and negative selection 4 main points to discuss: occurs in the thymus, naïve T cells mature and are subjected to central tolerance, recognition of self vs. non-self. IMPORTANT CONCEPT: Involves recognition of MCH class molecules in conjunction with self antigen. Positive selection – T cell receptor, antigen, MCH class molecule interaction is of a moderate strength, cells are positively selected. Anything to weak will not make it through MCH class restriction. Negative selection occurs when introduced to other cell in medulla, and the T cell receptor, antigen, MCH class molecule interaction is too strong. These cells are negatively selected. /12 3 MICROBIO320 EXAM 1-Fall 2009 Name _____________________________ Matching: Match the statement to the best word. Use the master list below. (1 point each) Please note that there may be more than one correct answer that matches to the definition. _EE__ 51. Fox3p is a specific marker for this kind of cell. __A__ 52. Major antibody found in secretions such as saliva, tears and breast milk. __T__ 53. This cell type always expresses MHC class II and MHC Class I molecules on the surface. __M__ 54. This molecule presents peptides that were processed through the proteasome and transported through TAP to the ER. _SY__ 55. This cell type requires the synthesis of granzymes and perforin for its function. __N__ 56. CD4 binds to this molecule during T cell activation. _AA__ 57. This cell type is specifically involved in antibody production. __F__ 58. This molecule on the antigen presenting cell is required for co-stimulation during a T cell response. __R__ 59. This cell type undergoes maturation in the bone marrow. _S,Y__ 60. This type of immune cell destroys target cells. P,M,N_ 61. This molecule participates in the adaptive immune response by forming a ternary complex. __C__ 62. Antibody type that sensitizes mast cells and causes degranulation. __E__ 63. Relatively high levels of this antibody isotype often correlates with first recent exposure to an inducing agent. __J__ 64. This molecule binds to B7. __V__ 65. This cell type is found in the bone marrow and is considered pluripotent. __G__ 66. The signal transduction molecule in the T cell receptor complex that sends the activation signal into the cells nucleus. Master List A. IgA Q. Basophil B. IgD R. B lymphocyte C. IgE S. Cytotoxic T lymphocyte D. IgG T. Dendritic cell E. IgM U. Eosinophil F. B7 V. Hematopoetic stem cell G. CD3 W. Macrophage H. CD4 X Naïve T lymphocyte I. CD8 Y. Natural Killer cell J. CD28 Z. Neutrophil K. CTLA-4 AA. Plasma cells L. Fox3p BB. Red blood cells M. MHC Class I CC. TH1 lymphocyte N. MHC Class II DD. TH2 lymphocyte O. B Cell receptor EE. Treg lymphocyte P. T Cell receptor /16 4 MICROBIO320 EXAM 1-Fall 2009 Name _____________________________ Multiple choice – Please circle the correct answer. (1 point each) 67. The heavy chain variable region of all classes/subclasses of Ig are encoded by: A. V & C gene segments. B. V & J gene segments. C. V gene segments only. D. V, D, & J gene segments. E. None of the above. 68. Which of the following is not a component of the specific adaptive immune response? A. T cells B. B cells C. Skin D. Macrophages E. All of the above 69. "Double positive" T lymphocytes are characterized by the following: A. high levels of FAS B. expression of low levels of Bcl-2 C. presence of CD4 and CD8 on the cell surface D. expression of low levels of the T cell receptor E. All of the above 70. The following are components of the membrane attack complex (MAC) except: A. C2 B. C9 C. C5b D. C7 E. C6 71. The development of self-tolerance in the T-cell compartment is important for the prevention of autoimmunity. Which of the following are examples of peripheral tolerance? A. ignorance B. negative selection C. thymocyte proliferation D. positive selection E. None of the above 72. The following activate(s) the alternative pathway of complement: A. lipopolysaccharides B. some viruses and virus-infected cells C. fungal and yeast cell walls (zymosin) D. many strains of gram-positive bacteria E. all of the above. 73. Which of the following is incorrect concerning MHC class II molecules? A. B cells may express different MHC class II molecules on their surface. B. MHC class II molecules are synthesized in the endoplasmic reticulum of many cell types. C. Genetically different individuals express different MHC class II alleles. D. MHC class II molecules are associated with b2-microglobulin on the cell surface. E. All are correct 5 MICROBIO320 EXAM 1-Fall 2009 Name _____________________________ 74. The class-specific antigenic determinants (epitopes) of immunoglobulins are associated with: A. L chains. B. J chains. C. disulfide bonds. D . H chains. E . variable regions. 75. Which statement about antigen epitopes is FALSE? A An epitope may be shared by two different antigens. B A protein molecule usually contains multiple epitopes. C T cells bind only processed antigen epitopes. D Some epitopes are more immunogenic than others. E. T cell and B cel recognize antigen identically 76. Which of the following components of complement possess the binding site for the Fc portion of antibodies? A. C1s B. C9 C. C1q D. C3 E. None of the above 77. A cell expressing which of the following is referred to as a “single positive cell”? A. TCR but not CD3 B. αβTCR but not γδTCR C. MHC class I but not MHC class II D. CD8 but not CD4 E. None of the above 78. Viral proteins that are formed inside of an infected cell associate with __________ and are presented at the surface of the infected cell.
Load more

Recommended publications
  • The Ligands for Human Igg and Their Effector Functions
    antibodies Review The Ligands for Human IgG and Their Effector Functions Steven W. de Taeye 1,2,*, Theo Rispens 1 and Gestur Vidarsson 2 1 Sanquin Research, Dept Immunopathology and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] 2 Sanquin Research, Dept Experimental Immunohematology and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1066 CX Amsterdam, The Netherlands; [email protected] * Correspondence: [email protected] Received: 26 March 2019; Accepted: 18 April 2019; Published: 25 April 2019 Abstract: Activation of the humoral immune system is initiated when antibodies recognize an antigen and trigger effector functions through the interaction with Fc engaging molecules. The most abundant immunoglobulin isotype in serum is Immunoglobulin G (IgG), which is involved in many humoral immune responses, strongly interacting with effector molecules. The IgG subclass, allotype, and glycosylation pattern, among other factors, determine the interaction strength of the IgG-Fc domain with these Fc engaging molecules, and thereby the potential strength of their effector potential. The molecules responsible for the effector phase include the classical IgG-Fc receptors (FcγR), the neonatal Fc-receptor (FcRn), the Tripartite motif-containing protein 21 (TRIM21), the first component of the classical complement cascade (C1), and possibly, the Fc-receptor-like receptors (FcRL4/5). Here we provide an overview of the interactions of IgG with effector molecules and discuss how natural variation on the antibody and effector molecule side shapes the biological activities of antibodies. The increasing knowledge on the Fc-mediated effector functions of antibodies drives the development of better therapeutic antibodies for cancer immunotherapy or treatment of autoimmune diseases.
    [Show full text]
  • "Epitope Mapping: B-Cell Epitopes". In: Encyclopedia of Life Sciences
    Epitope Mapping: B-cell Advanced article Epitopes Article Contents . Introduction GE Morris, Wolfson Centre for Inherited Neuromuscular Disease RJAH Orthopaedic Hospital, . What Is a B-cell Epitope? . Epitope Mapping Methods Oswestry, UK and Keele University, Keele, Staffordshire, UK . Applications Immunoglobulin molecules are folded to present a surface structure complementary to doi: 10.1002/9780470015902.a0002624.pub2 a surface feature on the antigen – the epitope is this feature of the antigen. Epitope mapping is the process of locating the antibody-binding site on the antigen, although the term is also applied more broadly to receptor–ligand interactions unrelated to the immune system. Introduction formed of highly convoluted peptide chains, so that resi- dues that lie close together on the protein surface are often Immunoglobulin molecules are folded in a way that as- far apart in the amino acid sequence (Barlow et al., 1986). sembles sequences from the variable regions of both the Consequently, most epitopes on native, globular proteins heavy and light chains into a surface feature (comprised of are conformation-dependent and they disappear if the up to six complementarity-determining regions (CDRs)) protein is denatured or fragmented. Sometimes, by acci- that is complementary in shape to a surface structure on the dent or design, antibodies are produced against linear antigen. These two surface features, the ‘paratope’ on the (sequential) epitopes that survive denaturation, though antibody and the ‘epitope’ on the antigen, may have a cer- such antibodies usually fail to recognize the native protein. tain amount of flexibility to allow an ‘induced fit’ between The simplest way to find out whether an epitope is confor- them.
    [Show full text]
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • Epstein-Barr Virus Epitope-Major Histocompatibility Complex
    University of Massachusetts Medical School eScholarship@UMMS Open Access Articles Open Access Publications by UMMS Authors 2020-03-17 Epstein-Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor alpha and beta Repertoires Anna Gil University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/oapubs Part of the Hemic and Lymphatic Diseases Commons, Immune System Diseases Commons, Immunology and Infectious Disease Commons, Infectious Disease Commons, Microbiology Commons, Virus Diseases Commons, and the Viruses Commons Repository Citation Gil A, Kamga L, Chirravuri-Venkata R, Aslan N, Clark FG, Ghersi D, Luzuriaga K, Selin LK. (2020). Epstein- Barr Virus Epitope-Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor alpha and beta Repertoires. Open Access Articles. https://doi.org/10.1128/mBio.00250-20. Retrieved from https://escholarship.umassmed.edu/ oapubs/4191 Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 License. This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. RESEARCH ARTICLE Host-Microbe Biology crossm Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Downloaded from Selection of Diverse T Cell Receptor ␣ and ␤ Repertoires Anna Gil,a Larisa Kamga,b Ramakanth Chirravuri-Venkata,c Nuray Aslan,a Fransenio Clark,a Dario Ghersi,c Katherine Luzuriaga,b Liisa K.
    [Show full text]
  • Epitope Spreading: Lessons from Autoimmune Skin Diseases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REVIEW Epitope Spreading: Lessons From Autoimmune Skin Diseases Lawrence S. Chan,*† Carol J. Vanderlugt,‡ Takashi Hashimoto,§ Takeji Nishikawa,¶ John J. Zone,** Martin M. Black,†† Fenella Wojnarowska,‡‡ Seth R. Stevens,§§ Mei Chen,† Janet A. Fairley,¶¶ David T. Woodley,*† Stephen D. Miller,‡ and Kenneth B. Gordon†‡ *Medicine Service, Section of Dermatology, Lakeside Division, VA Chicago Health Care System, Chicago, Illinois, U.S.A.; Departments of †Dermatology and ‡Microbiology and Immunology, Northwestern University Medical School, Chicago, Illinois, U.S.A.; ¶¶Department of Dermatology, Kurume University School of Medicine, Kurume, Japan; ¶Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; **Medicine Service, Section of Dermatology, Salt Lake City VA Medical Center, Salt Lake City, Utah, U.S.A.; ††Department of Dermatopathology, Guy’s and St. Thomas Medical and Dental School, London, U.K.; ‡‡Department of Dermatology, The Oxford Radcliffe Hospital, Oxford, U.K.; §§Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.; ¶¶Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A. Autoimmune diseases are initiated when patients develop In experimental autoimmune animal diseases, ‘‘epitope aberrant T and/or B cell responses against self proteins. spreading’’ seems to have significant physiologic impor- These responses
    [Show full text]
  • Of T Cell Tolerance
    cells Review Strength and Numbers: The Role of Affinity and Avidity in the ‘Quality’ of T Cell Tolerance Sébastien This 1,2,† , Stefanie F. Valbon 1,2,†, Marie-Ève Lebel 1 and Heather J. Melichar 1,3,* 1 Centre de Recherche de l’Hôpital Maisonneuve-Rosemont, Montréal, QC H1T 2M4, Canada; [email protected] (S.T.); [email protected] (S.F.V.); [email protected] (M.-È.L.) 2 Département de Microbiologie, Immunologie et Infectiologie, Université de Montréal, Montréal, QC H3C 3J7, Canada 3 Département de Médecine, Université de Montréal, Montréal, QC H3T 1J4, Canada * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: The ability of T cells to identify foreign antigens and mount an efficient immune response while limiting activation upon recognition of self and self-associated peptides is critical. Multiple tolerance mechanisms work in concert to prevent the generation and activation of self-reactive T cells. T cell tolerance is tightly regulated, as defects in these processes can lead to devastating disease; a wide variety of autoimmune diseases and, more recently, adverse immune-related events associated with checkpoint blockade immunotherapy have been linked to a breakdown in T cell tolerance. The quantity and quality of antigen receptor signaling depend on a variety of parameters that include T cell receptor affinity and avidity for peptide. Autoreactive T cell fate choices (e.g., deletion, anergy, regulatory T cell development) are highly dependent on the strength of T cell receptor interactions with self-peptide. However, less is known about how differences in the strength Citation: This, S.; Valbon, S.F.; Lebel, of T cell receptor signaling during differentiation influences the ‘function’ and persistence of anergic M.-È.; Melichar, H.J.
    [Show full text]
  • A Murine CD8+ T Cell Epitope Identified in the Receptor-Binding
    Article A Murine CD8+ T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein Jihyun Yang 1,† , Eunjin Kim 1,2,†, Jong-Soo Lee 2 and Haryoung Poo 1,* 1 Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea; [email protected] (J.Y.); [email protected] (E.K.) 2 Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-42-860-4157 † These authors contributed equally to this study. Abstract: The ongoing COVID-19 pandemic caused by SARS-CoV-2 has posed a devastating threat worldwide. The receptor-binding domain (RBD) of the spike protein is one of the most important antigens for SARS-CoV-2 vaccines, while the analysis of CD8 cytotoxic T lymphocyte activity in preclinical studies using mouse models is critical for evaluating vaccine efficacy. Here, we immunized C57BL/6 wild-type mice and transgenic mice expressing human angiotensin-converting enzyme 2 (ACE2) with the SARS-CoV-2 RBD protein to evaluate the IFN-γ-producing T cells in the splenocytes of the immunized mice using an overlapping peptide pool by an enzyme-linked immunospot assay and flow cytometry. We identified SARS-CoV-2 S395–404 as a major histocompatibility complex (MHC) class I-restricted epitope for the RBD-specific CD8 T cell responses in C57BL/6 mice. Keywords: SARS-CoV-2; cell-mediated immunity; CD8 cytotoxic T lymphocyte; epitope; vaccine Citation: Yang, J.; Kim, E.; Lee, J.-S.; Poo, H.
    [Show full text]
  • B Cell Checkpoints in Autoimmune Rheumatic Diseases
    REVIEWS B cell checkpoints in autoimmune rheumatic diseases Samuel J. S. Rubin1,2,3, Michelle S. Bloom1,2,3 and William H. Robinson1,2,3* Abstract | B cells have important functions in the pathogenesis of autoimmune diseases, including autoimmune rheumatic diseases. In addition to producing autoantibodies, B cells contribute to autoimmunity by serving as professional antigen- presenting cells (APCs), producing cytokines, and through additional mechanisms. B cell activation and effector functions are regulated by immune checkpoints, including both activating and inhibitory checkpoint receptors that contribute to the regulation of B cell tolerance, activation, antigen presentation, T cell help, class switching, antibody production and cytokine production. The various activating checkpoint receptors include B cell activating receptors that engage with cognate receptors on T cells or other cells, as well as Toll-like receptors that can provide dual stimulation to B cells via co- engagement with the B cell receptor. Furthermore, various inhibitory checkpoint receptors, including B cell inhibitory receptors, have important functions in regulating B cell development, activation and effector functions. Therapeutically targeting B cell checkpoints represents a promising strategy for the treatment of a variety of autoimmune rheumatic diseases. Antibody- dependent B cells are multifunctional lymphocytes that contribute that serve as precursors to and thereby give rise to acti- cell- mediated cytotoxicity to the pathogenesis of autoimmune diseases
    [Show full text]
  • B Lymphocytes in Neuromyelitis Optica
    VIEWS & REVIEWS B lymphocytes in neuromyelitis optica Jeffrey L. Bennett, MD, ABSTRACT PhD Neuromyelitis optica (NMO) is an inflammatory autoimmune disorder of the CNS that predomi- ’ Kevin C. O Connor, PhD nantly affects the spinal cord and optic nerves. A majority (approximately 75%) of patients with Amit Bar-Or, MD, FRCP NMO are seropositive for autoantibodies against the astrocyte water channel aquaporin-4 Scott S. Zamvil, MD, (AQP4). These autoantibodies are predominantly IgG1, and considerable evidence supports their PhD pathogenicity, presumably by binding to AQP4 on CNS astrocytes, resulting in astrocyte injury Bernhard Hemmer, MD and inflammation. Convergent clinical and laboratory-based investigations have indicated that Thomas F. Tedder, PhD B cells play a fundamental role in NMO immunopathology. Multiple mechanisms have been H.-Christian von hypothesized: AQP4 autoantibody production, enhanced proinflammatory B cell and plasmablast Büdingen, MD activity, aberrant B cell tolerance checkpoints, diminished B cell regulatory function, and loss of Olaf Stuve, MD, PhD B cell anergy. Accordingly, many current off-label therapies for NMO deplete B cells or modulate Michael R. Yeaman, PhD their activity. Understanding the role and mechanisms whereby B cells contribute to initiation, Terry J. Smith, MD maintenance, and propagation of disease activity is important to advancing our understanding Christine Stadelmann, of NMO pathogenesis and developing effective disease-specific therapies. Neurol Neuroimmunol MD Neuroinflamm 2015;2:e104;
    [Show full text]
  • The Adaptive Immune Response B-Cells
    The Adaptive Immune Response B-cells The innate immune system provides immediate protection. The adaptive response takes time to develop and is antigen specific. Activation of B and T lymphocytes Naive Plasma cells Naive ADAPTIVE IMMUNITY The adaptive immune system consists of lymphocytes and their products, including antibodies. The receptors of lymphocytes are much more diverse than those of the innate immune system, but lymphocytes are not inherently specific for microbes, and they are capable of recognizing a vast array of foreign substances. http://www.pathologystudent.com/wp- content/uploads/2010/07/normal-lymphs.jpg There are two types of adaptive Immunity Humoral immunity: mediated by B lymphocytes and their secreted products, antibodies (also called immunoglobulins, Ig) that protects against extracellular microbes and their toxins. Cellular immunity: mediated by T lymphocytes and is responsible for defense against intracellular microbes. content/uploads/2011/05/adoptive_immunity.gif - sheng.com/wp - http://yang Types of Adaptive Immune Reponses Lymphocytes Although lymphocytes appear morphologically unimpressive and similar to one another, they are actually remarkably heterogeneous and specialized in molecular properties and functions. Lymphocytes and other cells involved in immune responses are not fixed in particular tissues (as are cells in most of the organs of the body) but are capable of migrating among lymphoid and other tissues and the vascular and lymphatic circulations. This feature permits lymphocytes to home to any site of infection. In lymphoid organs, different classes of lymphocytes are anatomically segregated in such a way that they interact with one another only when stimulated to do so by encounter with antigens and other stimuli.
    [Show full text]
  • Prenatal Allospecific NK Cell Tolerance Hinges on Instructive
    Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development This information is current as of September 23, 2021. Amir M. Alhajjat, Beverly S. Strong, Amanda E. Lee, Lucas E. Turner, Ram K. Wadhwani, John R. Ortaldo, Jonathan W. Heusel and Aimen F. Shaaban J Immunol 2015; 195:1506-1516; Prepublished online 1 July 2015; Downloaded from doi: 10.4049/jimmunol.1500463 http://www.jimmunol.org/content/195/4/1506 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2015/07/01/jimmunol.150046 Material 3.DCSupplemental References This article cites 45 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/195/4/1506.full#ref-list-1 Why The JI? Submit online. by guest on September 23, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development Amir M.
    [Show full text]
  • Structural Features of Human Immunoglobulin G That Determine Isotype-Specitic Differences in Complement Activation by Mi-Hua Tao,* Richard I.F
    Structural Features of Human Immunoglobulin G that Determine Isotype-specitic Differences in Complement Activation By Mi-Hua Tao,* Richard I.F. Smith,* and Sherie L. Morrison*r From the "Department of Microbiology and Molecular Genetics and IThe Molecular Biology Institute, University of California, Los Angeles, California 90024 Summary Although very similar in sequence, the four subclasses of human immunoglobulin G (IgG) differ markedly in their ability to activate complement. Glu318-Lys320-Lys322 has been identified as Downloaded from http://rupress.org/jem/article-pdf/178/2/661/1268014/661.pdf by guest on 30 September 2021 a key binding motif for the first component of complement, Clq, and is present in all isotypes of Ig capable of activating complement. This motif, however, is present in all subclasses of human IgG, including those that show little (IgG2) or even no (IgG4) complement activity. Using point mutants of chimeric antibodies, we have identified specificresidues responsible for the differing ability of the IgG subclasses to fix complement. In particular, we show that Ser at position 331 in 3/4 is critical for determining the inability of that isotype to bind Clq and activate complement. Additionally, we provide further evidence that levels of Clq binding do not necessarily correlate with levels of complement activity, and that Clq binding alone is not sufficient for complement activation. he classical pathway of complement activation is initi- tivation ability and an IgG4 with the hinge of IgG3, although T ated by immune complexes composed of antigen and ei- as flexible as wild-type IgG3, displays no detectable comple- ther IgM or IgG Abs.
    [Show full text]